Company intelligence / Profile preview

Concern GRANIT

Ownership: Private
Development stage: Commercial

Overview

Concern GRANIT JSC primarily develops integrated professional radio systems and cryptographic information protection technologies. During the COVID pandemic, its scientific center developed a patented electromagnetic suppression technology for SARS–CoV–2, realized in the TOR medical device intended to protect large groups from coronavirus exposure. No clinical trial results or pharmaceutical pipeline. The company's main reputation and expertise are outside healthcare/life sciences. Its products are used across Russia mainly for communications/security purposes.

Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

TOR

Commercial

Indications: COVID-19

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Concern GRANIT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Concern GRANIT.

Explore the full profile